Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02749851 · ClinicalTrials.gov registry record
Placenta Imaging Project
A clinical trial of High Risk Pregnancy, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 379
- Enrollment target
- 2
- Study locations
NCT02749851: Completed study of High Risk Pregnancy, sponsored by Oregon Health and Science University.
NCT02749851 is a study of High Risk Pregnancy that has completed, run by Oregon Health and Science University. The registered enrollment target is 379 participants, above the 290-participant average among 10 other High Risk Pregnancy trials with a reported enrollment target (31% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02749851, a study of High Risk Pregnancy, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 379 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to test the application of newly generated magnetic resonance imaging (MRI) protocols for the assessment of placental perfusion in human subjects. The primary objective is to validate and establish the utility of placental MRI in pregnant women. The study will be entirely MRI-technology based with collection of placental tissue at the time of infant delivery for later correlative studies.
Primary Outcome
This will allow perfusion changes across pregnancy to be quantified in women from the three study groups.
Conditions Studied
Interventions
- DEVICE MRI
- DEVICE MRI - IUGR
Study Locations (2)
Oregon
- Oregon Health and Science University - Portland
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 379 participants |
| Start Date | 2016-10-13 |
| Est. Completion | 2020-06-30 |
What the finished NCT02749851 record still lists
NCT02749851 is an observational study that tracks outcomes without assigning an intervention. The registered 379 participants enrollment target is mid-sized for trials with a published cap, above the 290-participant average among 10 other High Risk Pregnancy trials with a reported enrollment target (31% higher).
The record links to 1 condition, with High Risk Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT02749851 reports a single indexed study location in Oregon, Utah.
Frequently Asked Questions
What is clinical trial NCT02749851 about?
NCT02749851 is a clinical study titled "Placenta Imaging Project". The purpose of this study is to test the application of newly generated magnetic resonance imaging (MRI) protocols for the assessment of placental perfusion in human subjects. The primary objective is to validate and establish the utility of placental MRI in pregnant women. The study will be entirel...
What is the current status of trial NCT02749851?
This trial is currently completed. The enrollment target is 379 participants. The study started on 2016-10-13. Estimated completion is 2020-06-30.
What conditions does trial NCT02749851 study?
This clinical trial studies the following conditions: High Risk Pregnancy.
What interventions are being tested in trial NCT02749851?
The interventions under investigation include: MRI (DEVICE), MRI - IUGR (DEVICE).
Who is sponsoring clinical trial NCT02749851?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02749851 being conducted?
This trial has 2 study locations across Oregon, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for High Risk Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02749851's enrollment target sits among peer trials
379 3rd of 10 higher than 8 of 10 other High Risk Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other High Risk Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
Remote Fetal Monitoring in High Risk Pregnancies
RECRUITING
-
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
RECRUITING · Phase 2
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage
RECRUITING · NA
-
UCLA Perinatal Biospecimen Repository
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI